BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20250312T175656EDT-0549lFwkTs@132.216.98.100
DTSTAMP:20250312T215656Z
DESCRIPTION:Since 2020\, the 9IÖÆ×÷³§Ãâ·Ñ Engine has co-hosted an annual Women in
  Entrepreneurship Panel with Promoting Opportunities for Women in Engineer
 ing (POWE) to highlight 9IÖÆ×÷³§Ãâ·Ñ Faculty of Engineering alum or student entr
 epreneurs in Tech. Ever wondered what it would be like to start and manage
  your own startup? This panel is designed to answer these questions! The p
 anelists will share their experiences and answer your questions about beco
 ming an entrepreneur. There will also be a networking cocktail with the pa
 nelists following the discussion.\n\nDate: Thursday\, March 20\, 2025\n	Sch
 edule: 5:30-7:30pm ET\n	Location: 9IÖÆ×÷³§Ãâ·Ñ Engine Centre (FDA5) 3450 Universi
 ty Street\, Montreal\, QC H3A 0E8\n\nRegistration here!\n\n\nAbout our pan
 elists\n\nGeorgia Powell\n\nCo-Founder & CEO @ NURA Medical \n\nGeorgia Po
 well is the CEO and co-founder of NURA Medical. She holds a Master of Scie
 nce in Experimental Surgery with a concentration in Surgical Innovation fr
 om 9IÖÆ×÷³§Ãâ·Ñ. During her master's\, Georgia’s research focused on pediatric m
 usculoskeletal disorders with additional research efforts directed towards
  the provision of fluid therapy on postoperative recovery after major spin
 e surgery. Prior to her master's\, Georgia completed her Bachelor of Scien
 ce in Kinesiology (Honours)\, with research experience in neuroscience on 
 the effect of feedback on motor learning through electroencephalograms. He
 r innovative vision for technology-driven solutions and patient-centered c
 are inspired her to co-found NURA Medical.\n\n\nMadison Santos\n\nCSO & Co
 -Founder @ TissueTinker \n\nMadison Santos is the CSO and co-founder of Ti
 ssueTinker\, an early-stage biotech venture developing 3D bio printed in v
 itro tumor and organ models to pre-screen cancer therapeutic drug candidat
 es to improve the to-market rate of new cancer therapeutics. Madison is a 
 Biomedical Engineering Master's student in the 9IÖÆ×÷³§Ãâ·Ñ Biomedical Technolog
 y & Cell Therapy (BTCTRL) Laboratory\, and current PGSS Innovation Commiss
 ioner\, supporting the 9IÖÆ×÷³§Ãâ·Ñ graduate innovation ecosystem.\n\n\nKimia Sh
 afighi\n\nCEO & Co-Founder @ Biocene \n\nKimia Shafighi is the CEO and co-
 founder of Biocene\, a clean tech startup dedicated to developing sustaina
 ble solutions for water ecosystems impacted by harmful algae overgrowth. B
 iocene's innovative technology\, Algo\, harnesses eco-friendly mechanical 
 systems to clean water bodies while transforming algae biomass into valuab
 le products such as biofuels\, bioplastics\, and biocoke. With a bachelor’
 s in bioengineering and a master’s in neuroscience and machine learning fr
 om 9IÖÆ×÷³§Ãâ·Ñ and Mila\, Kimia has led Biocene from its inception t
 o its current pilot projects with Parks Canada. She is passionate about su
 stainability\, innovation\, and empowering women in entrepreneurship.\n
DTSTART:20250320T213000Z
DTEND:20250320T233000Z
SUMMARY:6th Annual Women in Entrepreneurship Panel
URL:/medhealthsci-gradstudies/channels/event/6th-annua
 l-women-entrepreneurship-panel-363727
END:VEVENT
END:VCALENDAR